Catalyzing the Critical Path Initiative: FDA's progress in drug development activities.

@article{Parekh2015CatalyzingTC,
  title={Catalyzing the Critical Path Initiative: FDA's progress in drug development activities.},
  author={Ameeta Parekh and ShaAvhree Y Buckman-Garner and Samuel McCune and R ONeill and M Geanacopoulos and Shashi Amur and Carina C. Clingman and Rod Barratt and Mario Rocca and Ivory D. Hills and Janet Woodcock},
  journal={Clinical pharmacology and therapeutics},
  year={2015},
  volume={97 3},
  pages={221-33}
}
The US Food and Drug Administration (FDA) has directed considerable effort towards modernizing its regulatory processes over the past decade to address the challenges in the drug development sector. Through partnerships and input from stakeholders, multiple initiatives are under way, many projects have been launched, several have resulted in tangible… CONTINUE READING